|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Galardin | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C20H28N4O4 |
||||||||||
| 分子量 | 388.46 | CAS No. | 142880-36-2 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 78 mg/mL (200.79 mM) | ||||||||
| Ethanol (warmed with 50ºC water bath) | 4 mg/mL (10.29 mM) | ||||||||||
| Water | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | Ilomastat (GM6001)は、MMP-1、MMP-2、MMP-3、MMP-7、MMP-8、MMP-9、MMP-12、MMP-14、およびMMP-26に対する広範囲のマトリックスメタロプロテアーゼ (MMP)阻害剤であり、それぞれKiは0.4 nM、0.5 nM、27 nM、3.7 nM、0.1 nM、0.2 nM、3.6 nM、13.4 nM、0.36 nMです。 |
|---|---|
| in vitro | Ilomastat (GM6001) inhibits human skin fibroblast collagenase with Ki of 0.4 nM when assayed with a synthetic thio ester substrate at pH 6.5, with 50-fold selectivity over two bacterial enzymes, thermolysin and Pseudomonas aeruginosa elastase. This compound (0.1 nM - 10 nM) inhibits gelatinase A and gelatinase B produced by T-cells, thus inhibits T-cell homing. |
| in vivo | Topical application of Ilomastat (GM6001) (400 μg/ml) prevents corneal ulceration after severe alkali injury. In rabbit model after stenting, it significantly inhibits intimal hyperplasia and intimalcollagen content, and increases lumen area in stented arteries without effects on proliferation rates. |
| キナーゼアッセイ | Collagenase assay | |
|---|---|---|
| Ilomastat (GM6001) is assayed using the synthetic thiol ester substrate Ac-Pro-Leu-Gly-SCH(i-Bu)CO-Leu-Gly-OEt at pH 6.5. The collagenase concentration is 1-2 nM, and the substrate concentrations are from 0.1 to 0.7 nM. Km is found to vary between 1.5 and 4 mM. | ||
| 細胞アッセイ | 細胞株 | MLL cells |
| 濃度 | 20 µM | |
| 反応時間 | 72 h | |
| 実験の流れ | Cell viability was measured after 72-h exposure to triapine with co-treatment of 20 µM ilomastat (GM6001) |
|
| 動物実験 | 動物モデル | Rabbit |
| 投薬量 | 100 mg/kg/day | |
| 投与方法 | subcutaneous | |
|

, , Mol Cancer, 2015, 14(1):83.

Data from [Data independently produced by , , J Biol Chem, 2016, 291(44):22977-22987]

Data from [Data independently produced by , , Sci Rep, 2015, 5:16951]
| Sos1 ablation alters focal adhesion dynamics and increases Mmp2/9-dependent gelatinase activity in primary mouse embryonic fibroblasts [ Cell Commun Signal, 2025, 23(1):116] | PubMed: 40033301 |
| Mesenchymal Stem Cells Restore Endothelial Integrity and Alleviate Emotional Impairments in a Diabetic Mouse Model via Inhibition of MMP-9 Activity [ Int J Mol Sci, 2025, 26(7)3355] | PubMed: 40244194 |
| Inhibition of matrix metalloproteinase-9 attenuates kidney fibrosis and cellular senescence in the transition from acute kidney injury to chronic kidney disease [ Ren Fail, 2025, 47(1):2499897] | PubMed: 40468751 |
| Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks [ Immunity, 2024, 57(2):287-302.e12] | PubMed: 38354704 |
| Extracellular vesicles from human urine-derived stem cells delay aging through the transfer of PLAU and TIMP1 [ Acta Pharm Sin B, 2024, 14(3):1166-1186] | PubMed: 38487008 |
| Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer [ Cell Rep Med, 2024, 5(2):101388] | PubMed: 38262412 |
| Epithelial tubule interconnection driven by HGF-Met signaling in the kidney [ Proc Natl Acad Sci U S A, 2024, 121(52):e2416887121] | PubMed: 39705305 |
| ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex [ EMBO Rep, 2024, 25(7):3090-3115] | PubMed: 38871984 |
| Matrix metalloproteinases mediate influenza A-associated shedding of the alveolar epithelial glycocalyx [ PLoS One, 2024, 19(9):e0308648] | PubMed: 39312544 |
| Decanoylcarnitine Inhibits Triple-Negative Breast Cancer Progression via Mmp9 in an Intermittent Fasting Obesity Mouse [ Technol Cancer Res Treat, 2024, 23:15330338241233443] | PubMed: 38409962 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。